WALTHAM, MASS. & DUBLIN– Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Horizon Therapeutics plc (Nasdaq: HZNP), today announced that they have entered into a… Read More
Elecsys IGRA SARS-CoV-2 test supports the better understanding of immune response to SARS-CoV-2 infection or vaccination The test detects T-cell response, which may play an important role in determining if immune protection has… Read More
The trial, which is recruiting patients and cancer survivors, will evaluate the use of cannabis oils for cancer-related symptom management. The first- national clinical trial of medical cannabis oil extracts… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment… Read More
VANCOUVER, BC — Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine’s nasal photodisinfection… Read More
